Endovascular Abdominal Aortic Aneurysm repair devices market is expected to witness high growth owing to the increasing number of patients suffering from abdominal aortic aneurysm (AAA) disease. The Abdominal aortic aneurysm (AAA) disease is growing more than 5% CAGR globally, particularly in Australia, US, and Europe. Australia is forecasted to see growth rate of more than 7% CAGR in the number of patients, similarly the US is projected to report growth rate of more than 3% CAGR in the number of patients, however, Europe is expected to witness slow growth rate of less than 2% CAGR in the prevalence of abdominal aortic aneurysm disease by 2022. These aforementioned factors for the growth of abdominal aortic aneurysm disease is going to impact the endovascular aneurysm repair device market hugely due to the growing number of patients, and increasing number of emergency cases due to sudden rupture of arteries.

The abdominal aortic aneurysm (AAA) disease is primarily caused during the old age majorly in the age group from 55-84 years. Largely, the number of cases in the age group of 65-74 is expected to grow more than 3% CAGR. The prevalence of disease in men is forecasted to grow more than 6% CAGR, whereas occurrence of disease in women is projected to grow more than 2% CAGR. The similar trends are expected to see in people with other medical conditions such as heart disease, hypertension, diabetes, and peripheral vascular disease.

[b]Browse Detail Market Report of Endovascular Abdominal Aortic Aneurysm repair devices market @[/b][color=#ff0000] https://www.millioninsights.com/industry-reports/endovascular-abdominal-aortic-aneurysm-repair-devices-market [/color]

The Abdominal aortic aneurysm disease is occurred when the body’s largest artery, Aorta, is widened with age or after major accidents. This lead to the rupture of the artery when blood pressure is increased leading to internal bleeding hence requiring emergency attention. Endovascular aneurysm repair (EAR) is the potential surgery that is majorly done to tightly seal the weak spots with endovascular stent grafts. It is a technique that is also used to treat disease other than abdominal aortic aneurysm (AAA) such as thoracic aortic aneurysm (TAA). Primarily, in US more than 80% of cases of abdominal aortic aneurysm (AAA) are handled with EAR devices.

Minimum stay at hospital, patients returning to normal activities, quality of life after operation, and less risk of death are the key driving factors that propel the market of endovascular abdominal aortic aneurysm repair devices. The market still has huge potential in technological advancements such as in dealing issues of blood leakage from the treated area, graft movements, and need of regular activities. The restraint that is expected to slightly reduce the growth rate is majorly related to the risks involved in the surgery such as blood clots in the legs, breathing problems, heart attacks, reaction to medicines, and infection in other body parts.

The market is segmented by endovascular abdominal aortic aneurysm techniques into Percutaneous EAR, Fenestrated EAR, Branched EAR, Hybrid EAR, and Adjunctive procedures in EAR. The market is segmented into infrarenal (infrarenal + percutaneous indications PEVAR) and Juxtarenal (suprarenal + fenestrated). The market is segmented by anatomy condition into traditional aneurysm and complex aneurysm. Traditional aneurysm is categorized as aneurysm with aortic neck length of 10mm and occurs commonly. Complex aneurysm is categorized with invariable aortic neck length. Endovascular abdominal aortic aneurysm repair devices are primarily used to treat infrarenal aneurysm majorly by using branched and fenestrated endovascular aortic techniques depending upon the level of risk and repair.

These advanced devices also allow endovascular management of juxtarenal potentially when a suitable landing zone for the iliac artery is not present.
The market is also segmented by region into North America, Latin America, Europe, Asia Pacific, and Middle East. North America accounts for the major market share globally due to the presence of maximum healthcare companies that are dedicated in providing the endovascular aneurysm repair (EAR) for the abdomen aortic aneurysm (AAA) disease. Particularly the US is forecasted to account for major market share among other countries in the region in the next seven years, due to the growing awareness about the EAR technique benefits over other aneurysm repair techniques.

The region is also very responsive in continuous innovation to handle issues and constraints with EAR technique. The European and the Asia Pacific region are forecasted to witness fastest growth due to the increasing number of patients enduring with the AAA disease. Particularly countries such as India, China, Japan, Germany, Italy, UK and Singapore accounts for major market share because of increasing foreign investments with EAR devices to cure the disease. Middle East & African region is an untouched market due to lack of awareness about EAR techniques. In the next seven years, the region is expected show a substantial growth in the EAR devices market.

[b]Request Sample Copy of Endovascular Abdominal Aortic Aneurysm repair devices market @[/b][color=#ff0000] https://www.millioninsights.com/industry-reports/endovascular-abdominal-aortic-aneurysm-repair-devices-market/request-sample [/color]

The endovascular aneurysm repair devices include Zenith Flex (Cook Medical, Inc.), GORE EXCLUDER (W. L. Gore & Associates, Inc.), AneuRx AAA stent-graft system (Medtronic, Inc.), and Talent Abdominal Stent Graft (Medtronic, Inc.). Few other devices include IntuiTrak Powerlink System (outside the U.S.) and AFX Endovascular AAA System by Endologix, Inc. (in the U.S.). Devices are differed by the usage of graft material and stent material. These materials are polytetrafluoroethylene (ePFTE), and woven polyester. Key players in the market include, Cardiatis S.A., Bolton Medical, Inc., Cook Medical Inc., LeMaitre Vascular Inc., Cordis Corporation, TriVascular, Inc., JOTEC GmbH, TriVascular, Inc., Terumo Cardiovascular Systems Corporation, Medtronic, Inc., Endologix Inc., Lombard Medical Technologies plc, Aptus Endosystems Inc., Nano Endoluminal, Vascutek Ltd., and W. L. Gore & Associates.

[b]Get in touch[/b]

At [b]Million Insights[/b], we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

[b]Contact Information:[/b]
[b]Ryan Manuel[/b]
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016
Phone Number
91-20-65300184
Email Us: [b][email protected][/b]
Our Website: [b][color=#ff0000]https://www.millioninsights.com/[/color][/b]
Visit our Blog:[b][color=#ff0000]www.millioninsights.blogspot.com[/color][/b]